NASDAQ : BMRA

Biomerica, Inc.

$1.625 USD

-$0.01 (-0.31%)

Volume
2.87K
Average Volume
17.01K
Market Capitalization
$5.02M
P/E Ratio
-1.55
Dividend Yield
0.00%
Price Target
Year High
$4.60
Year Low
$1.61
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.64
Company Overview

NASDAQ

Zackary S. Irani

Medical - Devices

Healthcare

BMRA

54

US

USD

https://www.biomerica.com

949 645 2111

09061H406

0000073290

Liquidity Metrics

0.06

2.64

1.59

0.86

0.00

Sales & Valuation

$5.31M

1.16

1.47

-1.58

-1.05

Profitability

-$2.16

-$4.97M

-96.49%

-96.00%

-98.14%

-85.57%

P/E Metrics

-1.55

0.01

0.01

Analyst Price Target & Rating

Sell

2/5

3 Analysts

%

Poll Results

About Biomerica, Inc. (NASDAQ:BMRA) Stock

Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addressing a range of medical conditions and diseases. The company's diagnostic testing kits analyze patient samples, such as blood, urine, or stool, to pinpoint various illnesses and health complications. These kits are also capable of quantifying minute concentrations of specific substances like bacteria, hormones, antibodies, antigens, or other compounds present in bodily fluids or waste. Biomerica primarily sells its products for gastrointestinal disorders, food sensitivities, diabetes, and a variety of specialized diagnostic evaluations. Its distribution channels include physicians' clinics, re ... tail pharmacies, and hospital/clinical laboratories. The company is currently developing InFoods, a diagnostic-guided therapy technology for irritable bowel syndrome; products for Helicobacter pylori; and comprehensive diagnostic tools for COVID-19, encompassing their development, testing, validation, and sale. Established in 1971, Biomerica, Inc. maintains its corporate headquarters in Irvine, California.

Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development

2026-05-28 08:19:00

Auto-renewing Master Services Agreement engages Biomerica's integrated development and manufacturing platform, reflecting the Company's CDMO strategy as a capital-efficient, parallel revenue stream alongside its core inFoods® IBS program Auto-renewing Master Services Agreement engages Biomerica's integrated development and manufacturing platform, reflecting the Company's CDMO strategy as a capital-efficient, parallel revenue stream alongside its core inFoods® IBS program

Biomerica's inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026

2026-04-29 08:19:00

Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world's largest GI medical conference, May 2–5, 2026, in Chicago Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world's largest GI medical conference, May 2–5, 2026, in Chicago

Frequently Asked Questions

What is the current Biomerica, Inc. (BMRA) stock price?

Biomerica, Inc.(NASDAQ:BMRA) stock price is $1.625 in the last trading session. During the trading session, BMRA stock reached the peak price of $4.6 while $1.61 was the lowest point it dropped to. The percentage change in BMRA stock occurred in the recent session was --0.31% while the dollar amount for the price change in BMRA stock was -$0.01.

BMRA's industry and sector of operation?

The NASDAQ listed BMRA is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of BMRA?

Gary Lu | Principal Accounting Officer
Allen C. Barbieri | Executive Vice-Chairman of the Board & Corporate Secretary
Scott Madel | Chief Commercial Officer
Zackary S. Irani | Chief Executive Officer & Director
Lucy Liu | Director of Manufacturing & Technical Operations

How many employees does BMRA have?

Number of BMRA employees currently stands at 54. BMRA operates from 17571 Von Karman Avenue, Irvine, CA 92614, US.

Link for BMRA official website?

Official Website of BMRA is: https://www.biomerica.com

How do I contact BMRA?

BMRA could be contacted at phone #949 645 2111 and can also be accessed through its website. BMRA operates from 17571 Von Karman Avenue, Irvine, CA 92614, US.

How many shares of BMRA are traded daily?

The average number of BMRA shares traded daily for last 3 months was 17.01K.

What is the market cap of BMRA currently?

The market value of BMRA currently stands at $5.02M with its latest stock price at $1.625